Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000

• Autor(a) principal: Barth, Afonso Luis
• Data de Publicação: 2001
• Outros Autores: Rossi, Flavia, Dias, Cícero Armídio Gomes, Teixeira, Lucia, Sader, Hélio S., Blosser, Renée S., Jones, Mark E., Sahm, Daniel F., Thornsberry, Clyde, Yamakita, Juri, Karlowsky, James A., Mendes, Caio, Critchley, Ian A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/37736
• topic: Streptococcus pneumoniae; Haemophilus influenzae; Moraxella catarrhalis; Resistência bacteriana; Streptococcus pneumoniae; Antimicrobial resistance; Surveillance study; Respiratory pathogen

The in vitro antimicrobial susceptibility of the respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to commonly tested and prescribed agents was investigated during 1999-2000 and compared with results obtained during a previous 1997-1998 study. Of 448 isolates of S. pneumoniae collected and tested in 1999-2000, 77.2% were susceptible, 19.9% were intermediate, and 2.9% were resistant to penicillin, demonstrating that there were no major changes in susceptibility to penicillin from 1997-1998 (77.1% susceptible, 18.7% intermediate, 4.2% resistant). All S. pneumoniae isolates from 1999-2000 were susceptible to levofloxacin and vancomycin, and >90% were susceptible to the b-lactams (amoxicillin-clavulanate, ceftriaxone, and cefuroxime) and macrolides (azithromycin and clarithromycin), showing that susceptibility to these agents also remained unchanged since 1997-1998. The most notable increase in resistance between the two studies was demonstrated by trimethoprim-sulfamethoxazole, which increased from 23.4% to 38.6%. Penicillin resistance correlated with resistance to b-lactams, macrolides, and trimethoprim- sulfamethoxazole in both studies. In H. influenzae, the prevalence of b-lactamase-producing isolates remained unchanged (10.6% in 1999-2000; 11.0% in 1997-1998). All H. influenzae isolates were susceptible to levofloxacin, ceftriaxone, cefuroxime, and azithromycin, and showed no change between the two studies. Trimethoprim-sulfamethoxazole resistance was present in 40.1% of isolates in 1999- 2000, and in 45.2% in 1997-1998. In M. catarrhalis, the prevalence of b-lactamase-producing isolates was unchanged (97.9% in 1999-2000; 98.0% in 1997-1998). The most active agents against M. catarrhalis were azithromycin (MIC90, <0.03 mg/ml) and levofloxacin (MIC90, 0.03 mg/ml). Overall, these results suggest that, in Brazil, between 1999-2000 and 1997-1998, there have been no significant changes in the susceptibility of respiratory pathogens to any of the commonly tested and prescribed agents with the exception of trimethoprim-sulfamethoxazole for S. pneumoniae.